Citation Impact

Citing Papers

Microbiota in health and diseases
2022 Standout
The regulation of IL-10 production by immune cells
2010 Standout
Detection of a novel macrophage-derived mucus secretagogue (MMS-68) in bronchoalveolar lavage fluid of patients with asthma
1995
Modulation of asthma by endotoxin
2010
COPD Guidelines: A Review of the 2018 GOLD Report
2018 Standout
Nonredundant roles of TIRAP and MyD88 in airway response to endotoxin, independent of TRIF, IL-1 and IL-18 pathways
2006 StandoutNobel
Severity of asthma is related to endotoxin in house dust.
1996
Effect of Spinal Cord Injury on the Respiratory System
2003
Negative pressure ventilation in the treatment of acute respiratory failure: an old noninvasive technique reconsidered
1996
Pulmonary fibrosis: pathogenesis, etiology and regulation
2009 Standout
TLR4 mutations are associated with endotoxin hyporesponsiveness in humans
2000 Standout
Non-invasive positive pressure ventilation for treatment of respiratory failure due to exacerbations of chronic obstructive pulmonary disease
2004
Non-invasive positive pressure ventilation for treatment of respiratory failure due to exacerbations of chronic obstructive pulmonary disease
2003
Infection: friend or foe in the development of atopy and asthma?
2001
Exposure to Environmental Microorganisms and Childhood Asthma
2011 Standout
Role of ventilation in airborne transmission of infectious agents in the built environment ? a multidisciplinary systematic review
2007 Standout
Environmental Exposure to Endotoxin and Its Relation to Asthma in School-Age Children
2002 Standout
Allergic Rhinitis and Its Impact on Asthma
2001 Standout
Total and respirable airborne dust endotoxin concentrations in three equine management systems
1998
Tumor necrosis factor-alpha increases airway responsiveness and sputum neutrophilia in normal human subjects.
1995
The development of allergic inflammation
2008 StandoutNature
Grain Dust and Endotoxin Inhalation Challenges Produce Similar Inflammatory Responses in Normal Subjects
1996
An airbone mold-derived product, β-1,3-D-glucan, potentiates airway allergic responses
1999
Asthma
2001 Standout
Immunopathology of fatal soybean dust-induced asthma
1996
Indoor allergens and asthma:Report of the Third International Workshop
1997
Inflammatory response after inhalation of bacterial endotoxin assessed by the induced sputum technique
1998
Airborne (1→3)-β-d-Glucan and Airway Disease in a Day-Care Center before and after Renovation
1997
R‐form LPS, the master key to the activation ofTLR4/MD‐2‐positive cells
2006 StandoutNobel
Effect of surgical lung volume reduction on respiratory muscle function in pulmonary emphysema
1996 Standout
Traumatic spinal cord injury
2017 Standout
Does environmental endotoxin exposure prevent asthma?
2002
Exposure to farming in early life and development of asthma and allergy: a cross-sectional survey
2001 Standout
Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline
2017 Standout
Modulation by interleukin-4 of cytokine release from mononuclear phagocytes in asthma
1994
Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsìveness, and the late asthmatic response
2000 Standout
Mast cells in the development of adaptive immune responses
2005 Standout
Something old, something new: Indoor endotoxin, allergens and asthma
2004
The Measurement and Health Impact of Endotoxin Contamination in Organic Dusts from Multiple Sources: Focus on the Cotton Industry
2004
Animal models of acute lung injury
2008 Standout
The role of endotoxin and its receptors in allergic disease
2005
(1 → 3)- β - d -Glucan and Endotoxin in House Dust and Peak Flow Variability in Children
2000
Asthma
2000 Standout
Leukocyte-Derived IL-10 Reduces Subepithelial Fibrosis Associated with Chronically Inhaled Endotoxin
2006
Local Inflammatory Responses following Bronchial Endotoxin Instillation in Humans
2001
Effect of Inhaled Interleukin-5 on Airway Hyperreactivity and Eosinophilia in Asthmatics
1998
Modification of the Inflammatory Response to Allergen Challenge after Exposure to Bacterial Lipopolysaccharide
2000
House Dust Endotoxin and Wheeze in the First Year of Life
2001
Variable Airway Responsiveness to Inhaled Lipopolysaccharide
1999
Endotoxin Exposure as a Major Determinant of Lung Function Decline in Pig Farmers
1998
Dose-Response Relationship to Inhaled Endotoxin in Normal Subjects
1997
American Thoracic Society Statement
2003 Standout
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Inflammatory Airway Disease of Horses—Revised Consensus Statement
2016 Standout
The Role of Selenium in Inflammation and Immunity: From Molecular Mechanisms to Therapeutic Opportunities
2011 Standout
Th2 Cytokine Production from Mast Cells Is Directly Induced by Lipopolysaccharide and Distinctly Regulated by c-Jun N-Terminal Kinase and p38 Pathways
2002
IL-10 reduces grain dust-induced airway inflammation and airway hyperreactivity
2000
The Enigmatic Epidemiology of Nasopharyngeal Carcinoma
2006 Standout
NF-κB Family of Transcription Factors: Central Regulators of Innate and Adaptive Immune Functions
2002 Standout
Pollutants and asthma: role of air toxics.
2002
Coarse Particulate Matter (PM 2.5–10 ) Affects Heart Rate Variability, Blood Lipids, and Circulating Eosinophils in Adults with Asthma
2007
Microbial Cell Wall Constituents in Indoor Air and their Relation to Disease
1998
Filamentous microorganisms and their fragments in indoor air--a review.
2004 Standout
IL-9 and IL-13 Production by Activated Mast Cells Is Strongly Enhanced in the Presence of Lipopolysaccharide: NF-κB Is Decisively Involved in the Expression of IL-9
2001
Air Pollution and Cardiovascular Disease
2004 Standout
Bioaerosol Health Effects and Exposure Assessment: Progress and Prospects
2003 Standout
The Hidden World within Plants: Ecological and Evolutionary Considerations for Defining Functioning of Microbial Endophytes
2015 Standout
Building-Related Illnesses
1997
Mycotoxins
2003 Standout
Environmental tobacco smoke, indoor allergens, and childhood asthma.
2000
CpG Motifs in Bacterial DNA and Their Immune Effects
2002 Standout
The Asthma Epidemic
2006 Standout
Exposure to endotoxin or other bacterial components might protect against the development of atopy
2000
Tumour necrosis factor‐α: The role of this multifunctional cytokine in asthma
2001
The COPDX Plan: Australian and New Zealand Guidelines for the management of Chronic Obstructive Pulmonary Disease 2003
2003 Standout
Interleukin-10 and the Interleukin-10 Receptor
2001 Standout
Emissions of Metals Associated with Motor Vehicle Roadways
2004 Standout
Bacterial DNA or Oligonucleotides Containing Unmethylated CpG Motifs Can Minimize Lipopolysaccharide-Induced Inflammation in the Lower Respiratory Tract Through an IL-12-Dependent Pathway
1999
Particulate Matter Air Pollution and Cardiovascular Disease
2010 Standout
Lipopolysaccharide Endotoxins
2002 Standout
Longitudinal study of dust and airborne endotoxin in the home.
2000
Primary biological aerosol particles in the atmosphere: a review
2012 Standout
Effects of exposure to grain dust in Polish farmers: work-related symptoms and immunologic response to microbial antigens associated with dust.
1998
The Pathophysiology of Asthma
2002

Works of Roberta Ginanni being referenced

Protective Effect of Sodium Cromoglycate on Lipopolysaccharide-lnduced Bronchial Obstruction in Asthmatics
1995
Neural Respiratory Drive and Neuromuscular Coupling in Patients with Chronic Obstructive Pulmonary Disease (COPD)
1990
Domestic endotoxin exposure and clinical severity of asthma
1991
Inflammatory Response to Acute Inhalation of Endotoxin in Asthmatic Patients
1992
Physiologic Effects of Negative Pressure Ventilation in Acute Exacerbation of Chronic Obstructive Pulmonary Disease
2001
Ventilatory and Respiratory Muscle Responses to Hypercapnia in Patients with Paraplegia
2000
Relation between the bronchial obstructive response to inhaled lipopolysaccharide and bronchial responsiveness to histamine.
1992
Iron lung treatment of acute on chronic respiratory failure: 16 yrs of experience.
1994
Rankless by CCL
2026